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        INTRODUCTION  
  G protein  –  coupled receptors (GPCRs) are critical links 
in relaying information from the extracellular space to 
the intracellular environment. Elucidating the regula-
tion of GPCRs is an essential step in understanding cel-
lular physiology (  Clark, 1986  ;   Palczewski and Benovic, 
1991  ;   Burns and Baylor, 2001  ;   Kohout and Lefkowitz, 
2003  ). To date, the coordination of GPCR desensiti-
zation and cyclic nucleotide phosphodiesterase (PDE) 
activity in controlling cyclic nucleotide signals is best 
understood in sensory neurons (  Detlev and Restrepo, 
1998  ;   Burns and Baylor, 2001  ;   Fain et al., 2001  ). In par-
ticular, the unique structure of retinal rod outer seg-
ments, high concentrations of signaling proteins such as 
rhodopsin (    3 mM), and endogenous cyclic nucleotide-
gated channels have allowed integration of data ob-
tained both in vitro and in vivo, and provided unique 
insight into this signaling system (  Stryer, 1991  ;   Lagnado 
and Baylor, 1992  ;   Pugh and Lamb, 1993  ;   Yarfi  tz and 
    Abbreviations used in this paper: AC, adenylyl cyclase; AKAP, A-kinase an-
choring protein;     2AR,       2   adrenergic receptor; CNG, cyclic nucleotide-
gated; GPCR, G protein  –  coupled receptor; GRK, G protein  –  coupled 
receptor kinase; HEK, human embryonic kidney; PDE, phospho-
diesterase; PKI, a peptide inhibitor of PKA; PTX, pertussis toxin. 
Hurley, 1994  ;   Yau, 1994  ;   Polans et al., 1996  ;   Pugh et al., 
1997  ;   Molday, 1998  ). 
  Other GPCR-mediated signaling systems are not as 
well understood. This is especially true of       2   adrenergic 
receptor (    2AR)  –  mediated signaling pathways. The low 
cellular concentrations of these receptors, the existence 
of multiple receptor subtypes in a single cell, the lack of 
specifi  city of protein kinase inhibitors, and, until re-
cently, the inability to measure cAMP signals in single 
cells, have signifi  cantly hindered efforts to unravel the 
relative contributions of     2AR desensitization and PDE 
activity in shaping cAMP signals (  Clark and Rich, 2003  ). 
For these reasons, investigators have relied on the 
overexpression or knockdown of receptors, G protein  –
  coupled receptor kinases (GRKs), arrestin, or PDEs to 
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  An important focus in cell biology is understanding how different feedback mechanisms regulate G protein  – 
coupled receptor systems. Toward this end we investigated the regulation of endogenous       2   adrenergic receptors 
(    2ARs) and phosphodiesterases (PDEs) by measuring cAMP signals in single HEK-293 cells. We monitored cAMP 
signals using genetically encoded cyclic nucleotide-gated (CNG) channels. This high resolution approach allowed 
us to make several observations. (a) Exposure of cells to 1   μ  M isoproterenol triggered transient increases in cAMP 
levels near the plasma membrane. Pretreatment of cells with 10   μ  M rolipram, a PDE4 inhibitor, prevented the 
decline in the isoproterenol-induced cAMP signals. (b) 1   μ  M isoproterenol triggered a sustained, twofold increase 
in phosphodiesterase type 4 (PDE4) activity. (c) The decline in isoproterenol-dependent cAMP levels was not sig-
nifi  cantly altered by including 20 nM PKI, a PKA inhibitor, or 3   μ  M 59-74E, a GRK inhibitor, in the pipette solution; 
however, the decline in the cAMP levels was prevented when both PKI and 59-74E were included in the pipette 
solution. (d) After an initial 5-min stimulation with isoproterenol and a 5-min washout, little or no recovery of 
the signal was observed during a second 5-min stimulation with isoproterenol. (e) The amplitude of the signal in 
response to the second isoproterenol stimulation was not altered when PKI was included in the pipette solution, 
but was signifi  cantly increased when 59-74E was included. Taken together, these data indicate that either GRK-
mediated desensitization of     2ARs or PKA-mediated stimulation of PDE4 activity is suffi  cient to cause declines in 
cAMP signals. In addition, the data indicate that GRK-mediated desensitization is primarily responsible for a sus-
tained suppression of     2AR signaling. To better understand the interplay between receptor desensitization and 
PDE4 activity in controlling cAMP signals, we developed a mathematical model of this system. Simulations of cAMP 
signals using this model are consistent with the experimental data and demonstrate the importance of receptor 
levels, receptor desensitization, basal adenylyl cyclase activity, and regulation of PDE activity in controlling cAMP 
signals, and hence, on the overall sensitivity of the system. 350   Roles of GRK and PDE Activities in     2AR-mediated Signaling 
demonstrate that GRK-mediated desensitization of     2ARs 
is also capable of causing decays in isoproterenol-induced 
cAMP transients. In addition, we present evidence that 
GRK-mediated desensitization, but not PKA-dependent 
stimulation of PDE4 activity, mediates the suppression 
of     2AR signaling over a 5-min wash period. On the 
basis of these data we developed a mathematical model 
of the       2  -adrenergic signaling system. Simulations using 
this model reproduced the major aspects of the observed 
cAMP signals and provide a framework with which we 
can interpret the concerted actions of receptor levels, 
GRK-mediated receptor desensitization, and PDE4 ac-
tivity in regulating cAMP signals. Abstracts describing 
parts of this work have already appeared (Rich, T.C., S.J. 
Vayttaden, R.B. Clark, and W.K. Xin. 2007a.   FASEB J  . 21:
A791; Rich, T.C., W.K. Xin, A.L. Britain, and J.W. Karpen. 
2007c.   FASEB J  . 21:A792). 
  MATERIALS AND METHODS  
  Cell Culture and Channel Expression 
  Culture and adenovirus infection of HEK-293 cells were performed 
as described previously (  Rich et al., 2000  ). In brief, HEK-293 cells 
were maintained in 10 ml of minimal essential medium (MEM; 
Life Technologies Inc.) containing 10% vol/vol FBS (Gemini), and 
grown in 100-mm culture dishes at 37  °  C in a humidifi  ed atmosphere 
of 95% air, 5% CO  2  . Cells were plated at     60% confl  uence in 
100-mm dishes for infection with an adenovirus encoding the 
C460W/E583M CNG channel at a multiplicity of infection of   
  10 pfu/cell (  Rich et al., 2001b  ). 2 h post-infection, hydroxyurea 
was added to the cell media at a fi  nal concentration of 1 mM to in-
hibit viral replication. 24 h post-infection, cells were detached with 
PBS containing 0.03% EDTA, resuspended in serum-containing 
media, and assayed within 12 h. All experiments were conducted 
at room temperature, 20  –  22  °  C. Unless otherwise stated, all rea-
gents were purchased from Sigma-Aldrich. 
  Measurement of PDE activity 
  Cyclic AMP PDE activity was measured according to the method of 
  Thompson and Appleman (1971  ) as detailed previously (  Hansen 
et al., 2000  ;   Richter and Conti, 2002  ; Rich et al., 2007). In brief, after 
incubation for various times with or without 1   μ  M isoproterenol, 
cells were harvested and homogenized in ice-cold hypotonic buffer 
containing 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 50 mM NaF, 
1 mM EDTA, 0.2 mM EGTA, 100 mM Na  2  PO  4  , 1.4 mM     -mercapto-
ethanol, 0.5% NP-40, 1   μ  M microcystin-LR, and a   “  complete prote-
ase inhibitor  ”   tablet (Roche Diagnostics). Cells were homogenized 
using an all-glass homogenizer. Aliquots of the homogenates were 
assayed for PDE activity using 1   μ  M cAMP as the substrate. PDE4 
activity was defi  ned as the fraction of cAMP PDE activity inhibited 
by 10   μ  M rolipram. Protein concentrations were determined using 
the Bio-Rad Laboratories, Inc. protein assay using BSA as a 
standard. Experiments were repeated at least three times. 
  Measurement of Total Cellular cAMP Levels 
  HEK-293 cells were plated at 33% confl  uence in 100-mm dishes 
and assayed 24  –  48 h later. Cells were washed and assayed in a 
solution containing (in mM): 145 NaCl, 4 KCl, 10 HEPES, 10   d  -
glucose, 1 MgCl  2  , 1 CaCl  2  , pH 7.4. Additions were made from 
10  ×   solutions. Reactions were terminated by addition of 1 N HCl 
(0.1 N HCl fi  nal) and plates were incubated on ice for 15 min, 
after which the cells were scraped from the dish. Cellular cAMP 
elucidate the molecular mechanisms that regulate    2AR 
signaling (  Clark, 1986  ;   Devic et al., 2001  ;   Friedman 
et al., 2002  ;   Kohout and Lefkowitz, 2003  ;   Xiang et al., 
2005  ;   Violin et al., 2006a,b  ). While these approaches 
have yielded tremendous amounts of information about 
what may be happening in endogenous signaling sys-
tems, it is well documented that cells have a remark-
able ability to adapt to the overexpression, knockout, or 
knockdown of specifi  c proteins (  Krumins and Gilman, 
2006  ;   Violin et al., 2006b  ). Thus, it is critical to com-
plement these approaches with studies of unperturbed 
signaling systems using real-time readouts of intracellu-
lar signals. 
  We previously examined the molecular mechanisms 
underlying transient, PGE  1  -induced cAMP signals in 
human embryonic kidney (HEK)-293 cells. We found 
that the rate of prostaglandin-induced cAMP synthesis 
does not signifi  cantly decay in these cells, at least in the 
time-frame of our experiments, and that in response 
to PGE  1  , PDE4 activity increased two- to threefold in 
a PKA-dependent manner (  Rich et al., 2001a  ; Rich 
et al., 2007). We next monitored cAMP concentration in 
single cells by measuring cyclic nucleotide-gated (CNG) 
channel activity in the whole cell patch clamp confi  gu-
ration. This approach allowed us to selectively disrupt 
PKA-mediated signaling using either PKI, a highly selec-
tive peptide inhibitor of PKA (  Cheng et al., 1986  ), or 
Ht31, a peptide that disrupts A-kinase anchoring pro-
tein (AKAP)  –  PKA interactions (  Carr et al., 1991  ). We 
observed that including either PKI or Ht31 in the pi-
pette solution signifi  cantly inhibited the decline in the 
cAMP response. These observations, in conjunction with 
biochemical and molecular approaches, demonstrated 
that PKA-mediated stimulation of PDE4 activity was pri-
marily responsible for the decline in transient, PGE  1  -
induced cAMP signals (  Willoughby et al., 2006  ; Rich 
et al., 2007). As part of our study we developed a quan-
titative model of PGE  1  -induced cAMP signals, and used 
this model to ask a simple question: what would happen 
to the time course of the observed cAMP signals if 
the receptors did desensitize? Surprisingly, simulations 
of the model indicated that in the presence of PKA-
mediated stimulation of PDE4 activity, receptor desensi-
tization would only have small effects on the time course 
of cAMP signals. 
  In the present work we test this prediction by studying 
the endogenous     2AR signaling system in the same 
HEK-293 cell line. Our results indicate that exposure of 
cells to isoproterenol, a     -adrenergic agonist, triggers a 
sustained, twofold increase in PDE4 activity, and that, by 
itself, this feedback mechanism is capable of causing 
decays in isoproterenol-induced cAMP transients. How-
ever, in contrast to the observations described above, we 
demonstrate that isoproterenol-induced cAMP signals 
remain transient when PKA-dependent stimulation of 
PDE4 activity is pharmacologically inhibited. Our results     Xin et al.  351 
signals do not signifi  cantly desensitize at the level of cAMP synthe-
sis (  Rich et al., 2001a  , 2007). Here we have expanded the model 
such that it can now be used to examine the effects of     2AR ex-
pression levels, as well as receptor desensitization, on cAMP sig-
nals. In this model, GRK activity triggers the desensitization of 
    2ARs, whereas elevated PKA activity stimulates PDE4 activity. 
PKA-mediated regulation of     2ARs is not considered. Initial 
conditions were obtained by setting the basal adenylyl cyclase 
activity and letting the system run to equilibrium (without stimu-
lating receptor activity). The equations used to describe this 
model are given below. Parameters and initial conditions are 
given in   Table I  .   
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  where [      tot  ] is the total concentration of receptors, [      *  ] is the 
concentration of activated receptor at the plasma membrane, 
  K    D   is the dissociation constant of isoproterenol, [        desense    ] is the 
concentration of desensitized     2ARs, [      int  ] is the concentra-
tion of internalized     2ARs,   k    GRK   is the rate constant of receptor 
phosphorylation by GRK,   k  r      pp   is the rate constant of receptor de-
phosphorylation, [  H  ] is the hormone concentration, [  G  s    ] is the 
total G  s   concentration, [  G  s  GTP  ] is the activated G  s   concentration, 
  AC  syn     is the maximal cAMP synthesis rate,   K  GsAC     is the equilibrium 
constant between activated G protein and AC,   k  act     is the rate 
constant of G  s   activation by     *, and   k  h     is the rate constant of 
GTP hydrolysis. We assumed the rate of cAMP synthesis was not 
dependent on [ATP], because, in our experiments, the intracellu-
lar levels of ATP were clamped at high concentrations compared 
with the   K    m   of AC for ATP (5 and 0.315 mM, respectively). [  N  ] 
is the total cAMP concentration, [  cAMP  ] is the concentration of 
free cAMP,   E    AC   is the cAMP synthesis rate, [  PDE  ] is the concentra-
tion of unphosphorylated PDE4,   k    PDE   is the cAMP hydrolysis rate 
constant for unphosphorylated PDE4, [  PDEp  ] is the concentra-
tion of phosphorylated PDE4,   k    PDEp   is the cAMP hydrolysis rate 
constant for phosphorylated PDE4,   K    m   is the Michaelis constant 
for PDE4, [  I  ] is the concentration of a competitive inhibitor such 
as rolipram, and   K    I   is the inhibition constant. The effects of 
59-74E (a peptide inhibitor of GRK) were modeled as an 80% 
levels were measured using an enzyme immunoassay (Cayman 
Chemical). Sample cAMP concentrations were calculated from 
standard curves. Data are presented as mean   ±   SEM, performed 
in triplicate. 
  Single Cell Measurement of cAMP Signals 
  The whole cell patch clamp technique was used to measure 
cAMP in single cells, as described previously (  Rich et al., 2001a  , 
2007). In brief, recordings were made by an HEKA EPC10 patch 
clamp amplifi  er system. To ensure adequate voltage control, 
pipette resistance was limited to 4 M     and averaged 2.2   ±   0.1 M     
(  n   = 115). Voltage offsets were zeroed with the pipette in the 
bath solution; no additional corrections were made for the 
liquid junction potential difference. Experiments with a series 
resistance-induced error in excess of 5 mV were discarded. After 
achieving whole cell confi  guration, the preparation was allowed 
to equilibrate for at least 10 min to ensure suffi  cient time for dialy-
sis of compounds from the patch pipette into the cell. Current 
records were typically sampled at 10 kHz and fi  ltered at 2 kHz 
and stored on a PC. Currents were recorded during 400-ms steps 
to a membrane potential of +20 mV from a holding potential 
of 0 mV. The pipette solution contained (in mM) 140 KCl, 
0.5 MgCl  2  , 10 HEPES, 5 Na  2  ATP, 0.5 Na  2  GTP, pH 7.4; the bath 
solution contained (in mM) 140 NaCl, 4 KCl, 10   d  -glucose, 
10 HEPES, and either 0.1 or 10 MgCl  2  , pH 7.4. PGE  1   and roli-
pram (Calbiochem) were added to control solutions from con-
centrated DMSO stocks (fi  nal DMSO concentrations   ≤  0.2%). 
Isoproterenol was dissolved in a solution of 0.1 mM ascorbate, 
1 mM thiourea, pH 7.0. PKI (Calbiochem), St-Ht31 (Promega), 
and the 59-74E peptide (Sigma-Genosys) were aliquoted as 1000 ×   
stock solutions and stored at     20  °  C. Extracellular solutions were 
applied using a SF-77B solution switcher (Warner Instruments) 
with a mechanical switch time of 1  –  2 ms. The time to exchange 
the extracellular solution was measured by applying a 140 mM 
KCl solution to a depolarized cell (+50 mV) and monitoring 
changes in current through endogenous voltage-gated K 
+   chan-
nels; for each experiment, it was   <  100 ms. The bulk solution 
within the bath chamber was changed within 20 s using a custom-
built, gravity-driven perfusion system. In some experiments, 
cells were treated with 100 ng/ml of pertussis toxin (PTX) for 
18  –  24 h before experiments to test for possible influence of 
PTX-sensitive G proteins in     2AR signaling. To ensure that PTX 
was active in our system, we demonstrated that PTX could 
inhibit sphingosine-1-phosphate  –  mediated Ca 
2+   release from 
intracellular stores (not depicted), as described previously 
(  van Koppen et al., 1996  ). The baseline current (non-CNG chan-
nel current) was monitored by measuring the residual current 
in the presence of 10 mM Mg 
2+   (a CNG channel blocker), approx-
imately once per minute. No Mg 
2+  -blockable currents were ob-
served in control cells (cells which do not express CNG channels). 
All data were analyzed using custom scripts written in the 
MATLAB programming environment (v 7.4, MathWorks), and 
statistical analysis was performed using Student  ’  s   t   test. Simula-
tions were conducted using the fourth order Runga Kutta 
method as implemented within the MATLAB programming 
environment. Electrophysiological data were converted to for-
mats compatible with MATLAB software using a custom script 
provided by Bruxton Corporation. 
  Mathematical Equations Describing the       2   Adrenergic 
Signaling Pathway 
  To investigate the relative contributions of receptor desensitiza-
tion and PDE activity in regulating cAMP signals, we developed a 
kinetic model of cAMP turnover near the plasma membrane of 
HEK-293 cells. This model is based on a recently published model 
of prostaglandin-induced cAMP signals in the same cells (Rich 
et al., 2007). Interestingly, in HEK-293 cells, prostaglandin-induced 352   Roles of GRK and PDE Activities in     2AR-mediated Signaling 
    
dP D E p
dt
k
PKI
K
C PDE k PDEp
PKA
IP K I
pp []
=
+
⋅[] ⋅[] −⋅ []
−
1 []      (11) 
  where   k    PKA   is the rate constant of PKA-mediated phosphory  -
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reduction in   k    grk  . The phosphorylation of PDE4 is described by 
the equations below. 
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  TABLE I  
  Parameters Used to Simulate Transient cAMP Signals Near the Plasma Membrane of HEK-293 Cells 
Parameter Parameter defi  nition Value Initial condition Reference
  [      tot  ] Total      2AR concentration 1   μ  M* *
  [    ]  Inactive receptor concentration 0.2   μ  M
  [    *]  Activated receptor concentration 0.8   μ  M
  [      desense  ]  Desensitized receptor concentration 0   μ  M
  [      int  ]  Internalized receptor concentration 0   μ  M
  k  GRK    Rate constant of receptor phosphorylation 0.005 s 
    1   Tran et al., 2004 
  k  rpp    Rate constant of receptor dephosphorylation 0.0005 s 
    1   Iyer et al., 2006  ;   Tran et al., 2007a 
  k  int    Rate constant of receptor internalization 0.01 s 
    1 
  k  rec    Rate constant of receptor recycling 0.005 s 
    1 
  k  act    Rate constant of G  s   activation of     2AR 15 s 
    1   Frace et al., 1993 
  k  h    Rate constant of GTP hydrolysis 0.8 s 
    1   Frace et al., 1993 
  K  D    Dissociation constant of isoproterenol 250 nM   Whaley et al., 1994 
  G  stot    Total concentration of G  s 4    μ  M ** with initial estimate from   Post et al., 1995 
  K  c    Equilibrium constant between activated receptor and G 
protein
15   μ  M
  K  GsAC    Equilibrium constant between activated G protein and AC 315   μ  M
  AC  syn    cAMP synthesis rate 10   μ  M  ·  s 
    1 **
AC  0  Basal cAMP synthesis rate 0.005   μ  M  ·  s 
    1 **
[  N  ] cAMP concentration 0.5   μ  M  Beavo et al., 1974 
  V    max-PDE  Maximal hydrolysis rate of unphosphorylated PDE 0.15   μ  M    s 
    1   Reeves et al., 1987  ;   Rich et al., 2001a  , 2007
  V    max-PDEp  Maximal hydrolysis rate of phosphorylated PDE 2.5       V    max-PDE  Rich et al., 2007
  K    m  Michaelis constant for PDE 1   μ  M  Houslay et al., 1998 
  K    I  Inhibition constant of rolipram 0.1   μ  M  Houslay et al., 1998  ;   Richter and Conti, 2004 
  K    1/2  cAMP concentration that half maximally activates CNG 
channels
1.1   μ  M  Rich et al., 2001a  ,  b 
  N Hill  coeffi  cient of cAMP binding to CNG channels 2.1   Dhallan et al., 1990  ;   Rich et al., 2001b 
  k    PKA  Rate constant of PKA-mediated phosphorylation 0.015   μ  M 
    1    ·  s 
    1 **
  k    pp  Rate constant of PDE dephosphorylation 0.005 s 
    1 **
[PKA] PKA concentration 1   μ  M  Beavo et al., 1974  ;   Hofmann et al., 1977  ;   Rich 
and Karpen, 2002 
  k    fa  Rate constant of cAMP binding to site a of the R subunit 5   μ  M 
    1    ·  s 
    1   Doskeland and Ogreid, 1984  ;   Rich and 
Karpen, 2002 
  k    fb  Rate constant of cAMP binding to site b 0.4   μ  M 
    1    ·  s 
    1   Doskeland and Ogreid, 1984  ;   Rich and 
Karpen, 2002 
  k    ra  Rate constant of cAMP dissociation from site a 1 s 
    1   Doskeland and Ogreid, 1984  ;   Houge et al., 
1990  ;   Rich and Karpen, 2002 
  k    rb  Rate constant of cAMP dissociation from site b 0.2 s 
    1   Doskeland and Ogreid, 1984  ;   Houge et al., 
1990  ;   Rich and Karpen, 2002 
  k  PKA      act  Rate constant of R and C subunit dissociation 70 s 
    1   Smith et al., 1981  ;   Houge et al., 1990  ;   Huang 
and Taylor, 1998  ;   Rich and Karpen, 2002 
  k  PKA      deact  Rate constant of R and C subunit association 0.75   μ  M 
    2    ·  s 
    1   Smith et al., 1981  ;   Houge et al., 1990  ;   Huang 
and Taylor, 1998  ;   Rich and Karpen, 2002 
  K    I-PKI  Inhibition constant of PKI 2.3 nM   Cheng et al., 1986 
Initial conditions were estimated based on steady-state parameter values in the presence of basal adenylyl cyclase activity. ** denotes values that were fi  t 
to the time course of cAMP signals as described in Rich et al. (2007). Concentrations of enzymes should be considered approximate, whether estimated 
or experimentally derived, because, with the exceptions of data provided from our work, experimentally derived data were obtained from other cellular 
systems, either overexpression systems or other cell types. In addition, there have been few studies estimating the localized concentrations of enzymes 
within signaling complexes.    Xin et al.  353 
The concentration of free cAMP and activation of CNG channels 
are described as follows: 
     [] c A M PNR CR C R CR R R a b ab a b ab = [] −[] −[] −⋅ [] −[] −[] −⋅ [] 22    
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  where   I/I    max   is the fractional current through CNG channels,   K    1/2   
is the concentration of cAMP that elicits half-maximal current, 
and   N   is the Hill coeffi  cient. 
  RESULTS  
  We and others recently reported that PKA-mediated ac-
tivation of PDE4 is an important mechanism for shaping 
GPCR-mediated signals (  Terrin et al., 2006  ;   Willoughby 
et al., 2006  ; Rich et al., 2007). To better understand 
the interplay between PDE activation and GPCR desen-
sitization in regulating cAMP signals we examined 
signaling via the endogenous     2ARs in HEK-293 cells. 
Cyclic AMP signals were monitored in single cells using 
CNG channels as real-time biosensors. CNG channels 
with the C460W and E583M mutations (C460W/E583M 
channels) were expressed in HEK-293 cells via adeno-
virus infection. These mutations increase both the spec-
ifi  city and the sensitivity of the channels to cAMP (  Rich 
et al., 2001b  ). CNG channel activity was measured using 
the whole cell voltage clamp technique, as described in 
the Materials and methods. The activation of C460W/
E583M channels in response to 20, 50, and 1000 nM iso-
proterenol is shown in   Fig. 1  .   CNG channel activation in 
response to 20 nM isoproterenol reached a steady pla-
teau over a 7-min stimulation, indicating a sustained in-
crease in cAMP levels. Conversely, channel activation in 
response to 50 and 1000 nM isoproterenol was transient, 
indicating an initial increase and subsequent decrease 
in cAMP levels near the plasma membrane. We next 
sought to determine the cellular mechanisms responsi-
ble for the transient cAMP signals observed in response 
to high concentrations of isoproterenol. 
  We previously reported that PKA-mediated stimu-
lation of PDE4 activity is primarily responsible for the 
decline in PGE  1  -induced cAMP signals in HEK-293 
cells; that 5-min stimulation with PGE  1  , forskolin, or iso-
proterenol triggers a PKA-dependent, two- to threefold 
increase in PDE4 activity; and that this stimulation of 
PDE4 is responsible for the decline in PGE  1  -induced 
cAMP signals (  Rich et al., 2001b  , 2007). By analogy, it 
seemed likely that PKA-mediated stimulation of PDE4 
activity also contributes to the decay of cAMP signals 
triggered by     -adrenergic agonists. To ensure that the 
time course of PDE4 activation was consistent with this 
hypothesis, we measured PDE4 activity in response to 
isoproterenol as described in the Materials and methods. 
Stimulation of HEK-293 cells with 1   μ  M isoproterenol 
inhibitor PKI,   k    pp   is the rate constant of phosphatase-mediated 
dephosphorylation, and [  C  ] is the concentration of free cata-
lytic PKA subunits. The equations describing PKA activity are 
given below. 
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  where   R   represents the regulatory subunit of PKA with two cAMP 
binding sites,   a   and   b  . [  RC  ] is the concentration of unliganded 
regulatory subunits bound to catalytic subunits, [  R    a    C  ] is the con-
centration with cAMP bound to site   a  , [  R    b    C  ] is the concentration 
with cAMP bound to site   b  , and [  R    ab    C  ] is the concentration with 
cAMP bound to sites   a   and   b  . The rate constants for cAMP bind-
ing and unbinding to sites   a   and   b   are   k    fa  ,   k    fb  , and   k    ra  ,   k    rb  . The rate 
constants for the dissociation and association of the   R   and   C   sub-
units are   k    act   and   k    deact  . Note that the dissociation and association 
of the   R   and   C   subunits are considered irreversible reactions. 354   Roles of GRK and PDE Activities in     2AR-mediated Signaling 
the effect of H89 (10   μ  M) on isoproterenol-induced 
(10   μ  M) cAMP accumulation in both the presence and 
absence of rolipram (a specifi  c inhibitor of PDE4)   using 
enzyme immunoassays (  Fig. 2 B  ). In these experiments 
triggered a threefold increase in PDE4 activity within 
1 min, followed by a slight reduction in activity to a 
sustained level of twofold over basal (  Fig. 2 A  ).   PDE4 
activation was inhibited by H89, a PKA inhibitor, in a 
dose-dependent manner (Rich et al., 2007). H89 did 
not affect the non-PDE4 activity, which contributes 
    50% of total PDE activity in these cells (unpublished 
data). Taken together, these data suggest that    -adrenergic 
agonists trigger PKA-mediated stimulation of PDE4 ac-
tivity, which may contribute to the decay of transient 
cAMP signals. 
  It has been proposed that PKA-mediated stimulation 
of GRK activity may have contributed to the time course 
of cAMP signals (  Cong et al., 2001  ). More recently, sev-
eral groups presented data consistent with an alternate 
proposal, that at high agonist concentrations PKA has 
little effect on     2AR activity (  Krasel et al., 2004, 2005  ; 
  Tran et al., 2004  ;   Violin et al., 2006b  ). In addition, it is 
possible that PKA-mediated inhibition of adenylyl cy-
clase activity could slow the rate of cAMP accumulation. 
To determine if PKA did indeed inhibit the rate of 
cAMP synthesis, either by inhibition of adenylyl cyclase 
activity or by stimulation of GRK activity, we measured 
  Figure 1.     Measurement of isoproterenol-induced cAMP signals 
near the plasma membrane of HEK-293 cells. HEK-293 cells were 
infected with CNG-channels that transduce cAMP signals to elec-
trical current. Responses were elicited by exposure of each cell to 
the indicated concentrations of isoproterenol. Shown are cAMP 
signals in response to 20 nM (A), 50 nM (B), and 1   μ  M (C) iso-
proterenol. All traces are representative of the range of responses 
from at least fi  ve experiments.     
  Figure 2.     Effects of PKA on isoproterenol (1   μ  M)-induced cAMP 
synthesis and hydrolysis in HEK-293 cells. (A) Time course of 
isoproterenol-induced stimulation of PDE4 activity in HEK-293 
cell extracts. Cells were incubated with 1   μ  M isoproterenol for 
the indicated times. At the end of the incubation, cells were har-
vested and homogenates subjected to PDE activity assays using 
1   μ  M cAMP as substrate. PDE activity was measured in the absence 
or presence of 10   μ  M rolipram. The rolipram-inhibited PDE4 
activity is reported. It is clear that isoproterenol induced a two- to 
threefold increase in PDE4 activity. The increase in PDE4 activ-
ity was due to PKA-dependent phosphorylation of PDE4 and was 
prevented by pretreatment with PKA inhibitors (not depicted). 
(B) cAMP accumulation measured in HEK-293 cells using an 
enzyme immunoassay. Cells were stimulated with 10   μ  M isopro-
terenol for 5 min following pretreatment with vehicle (DMSO, 
10 min), 10   μ  M H89 (10 min), 10   μ  M rolipram (5 min), or 10   μ  M 
H89 (10 min) and 10   μ  M rolipram (5 min). H89 had little or 
no effect on isoproterenol-induced cAMP accumulation in the 
presence of rolipram, indicating that PKA does not substantially 
stimulate receptor desensitization or inhibit the rate of cAMP 
synthesis following stimulation with saturating concentrations of 
isoproterenol. Data are the mean   ±   SEM of three (A) or four (B) 
separate experiments, each performed in triplicate.         Xin et al.  355 
the isoproterenol-induced cAMP signal, demonstrating 
the signifi  cance of PDE4 activity in shaping near-mem-
brane cAMP signals. It is important to note that roli-
pram will inhibit both basal and stimulated PDE4 activity 
(    99% of all PDE4 activity at 10   μ  M rolipram and 1   μ  M 
cAMP); whereas PKI will only inhibit PKA-mediated 
processes such as the stimulation of PDE4 activity, leav-
ing basal PDE4 activity intact. When either PKI (20 nM) 
or St-Ht31 (10   μ  M) were included in the pipette solu-
tion, no signifi   cant effects on isoproterenol-induced 
signals were observed (  Fig. 3, B and C  ). These results 
were in stark contrast to our previous observations that 
both PKI and St-Ht31 prevented the decline in PGE  1  -
induced cAMP signals in the same cells (Rich et al., 2007). 
Thus, it was apparent that mechanisms other than stim-
ulation of PDE4 activity contribute to shaping the time 
course of isoproterenol-induced cAMP signals. 
  One potential mechanism responsible for the decline 
in cAMP levels is G  i  -mediated inhibition of adenylyl 
cyclase activity. Several studies have demonstrated that 
purifi  ed     2AR or a synthetic peptide corresponding to 
the third intracellular loop of the     2AR can activate G  i   
in reconstituted systems, albeit with a signifi  cantly lower 
coupling effi  ciency relative to G  s   (  Cerione et al., 1985  ; 
  Rubenstein et al., 1991  ). To test this possibility, we 
treated cells with 100 ng/ml PTX for 18  –  24 h before 
measuring CNG channel activity, as described in the 
we used a higher isoproterenol concentration than in 
other experiments because H89 is a competitive antago-
nist of     2ARs (  Penn et al., 1999  ). The data demonstrate 
that H89 has little or no effect on isoproterenol-induced 
cAMP accumulation in the presence of rolipram. Thus, 
PKA does not inhibit cAMP synthesis triggered by satu-
rating concentrations of isoproterenol in this cellular 
system. These data are consistent with our previous 
work demonstrating that H89 had little or no effect on 
forskolin- or PGE  1  -induced cAMP accumulation in the 
presence of rolipram (Rich et al., 2007). 
  To further elucidate the molecular mechanisms un-
derlying near-membrane cAMP signals, we monitored 
isoproterenol-induced C460W/E583M channel activity 
in the presence of rolipram, PKI (a peptide inhibitor of 
PKA), PTX (an inhibitor of G  i  ), St-Ht31 (a peptide that 
disrupts AKAP-PKA complexes), and 59-74E (a peptide 
inhibitor of GRK characterized by Winstel et al., 2005). 
Inhibitors were included in the pipette solution to en-
sure that we exposed the intracellular space to known 
inhibitor concentrations. Representative traces of cAMP 
signals in the presence of these compounds are shown 
in   Fig. 3 (A  –  G)  .   The percentage of current remaining 
3 min after the peak current was used to quantify the 
extent to which the different compounds altered the 
decay in cAMP signals (  Fig. 3 H  ). Including rolipram 
(10   μ  M) in the pipette solution abolished the decline in 
  Figure 3.     Pharmacological profi  ling of the molecular mechanisms underlying transient isoproterenol-induced cAMP signals. Responses 
were elicited by exposure of CNG channel  –  expressing cells to 1   μ  M isoproterenol. (A) The decline in the cAMP transients was abolished 
when 10   μ  M rolipram (a PDE4 inhibitor) was included in the patch pipette. The decline in the response remained largely intact when 
20 nM PKI (a PKA inhibitor, B) or 10   μ  M St-Ht31 (an AKAP-PKA disruptor, C) were included in the patch pipette, indicating the PKA 
was not solely responsible for the decline in the signal. (D) An 18  –  24-h pretreatment with PTX (an inhibitor of G  i  ) had little effect on 
the overall kinetics of the signal. (E) 3   μ  M 59-74E (a GRK inhibitor) did not prevent the decline in the cAMP transients. However, the 
decline in the response was largely eliminated when both PKI and 59-74E (F) or St-Ht31 and 59-74E (G) were included in the patch 
pipette. (H) Data were quantifi  ed by measuring the percentage of current remaining 3 min after the peak current.     356   Roles of GRK and PDE Activities in     2AR-mediated Signaling 
were included in the patch pipette, the decline of the 
cAMP transient was blunted (  Fig. 3, G and H  ). Treatment 
with PTX had no additional effects on cells exposed to 
either 59-74E or PKI and 59-74E (  Fig. 3 H  ). Based upon 
these data, we propose that both GRK-mediated desen-
sitization (in the presence of basal PDE activity) and 
PKA-mediated stimulation of PDE4 activity are each suf-
fi  cient to dampen cAMP signals. 
  We then tested the effects of these pharmacological 
agents on signals elicited during a two-pulse stimulation 
with isoproterenol. During this protocol, cells were 
exposed to 1   μ  M isoproterenol for 5 min, washed for 
5 min, and then reexposed to 1   μ  M isoproterenol (  Fig. 4  ).   
There was little or no response to the second stimulation 
with isoproterenol when either vehicle or 20 nM PKI 
was included in the pipette solution (  Fig. 4, A, B, and E  ). 
In contrast, there was a substantial response to the sec-
ond pulse of isoproterenol when 59-74E was included in 
the pipette solution ( Fig. 4, C and E ). Interestingly, when 
both PKI and 59-74E were included in the pipette solu-
tion, there was substantial response to the second pulse 
of isoproterenol (  Fig. 4 D  ), but the relative amplitude of 
the second response was not signifi  cantly greater than 
with 59-74E alone (  Fig. 4 E  ). The incomplete recovery 
may be due to incomplete inhibition of GRK activity with 
59-74E, or to the presence of a GRK(s) that is not signifi  -
cantly inhibited by 59-74E. Based upon these observa-
tions, we propose that GRK-mediated desensitization is 
primarily responsible for the sustained suppression of 
cAMP signals during the 5-min wash period. 
  Materials and methods. We observed that some PTX-
treated cells displayed higher basal cAMP levels and 
slightly slower rates of decline in the transient cAMP signal 
(  Fig. 3 D  ); however, these results were not statistically 
signifi  cant (  Fig. 3 H  ). These data indicate that potential 
    2AR-mediated activation of G  i  , and subsequent inhibition 
of adenylyl cyclase activity, had little or no effect on the 
time course of cAMP signals in this cellular system. 
  Another possible mechanism that may underlie the 
transient responses is GRK-mediated receptor desensiti-
zation and the subsequent reduction in adenylyl cyclase 
activity. To test this possibility, we included the GRK in-
hibitor 59-74E (3   μ  M) in the pipette solution. 59-74E 
inhibits phosphorylation of rhodopsin by purifi  ed GRK 
subtypes 2, 3, and 5 with IC  50  s of 0.6, 1.5, and 1.6   μ  M, 
respectively (Winstel et al., 2005). Again, although small 
changes in the kinetics of the cAMP signal were ob-
served in some cells (  Fig. 3 E  ), overall, the decay of the 
signal was not signifi  cantly altered (  Fig. 3 H  ). Thus, in-
dividually, inhibition of PKA-mediated stimulation of 
PDE4 activity, preventing G  i   activity, or inhibition of 
GRK activity did not prevent the decline in isoproterenol-
induced cAMP signals. 
  We next sought to determine if multiple signaling 
pathways worked in concert to control the decline of 
cAMP signals. To test this possibility we included both 
PKI (20 nM) and 59-74E (3  μ  M) in the patch pipette solu-
tion. Under these conditions, the decay in isoprotere-
nol-induced cAMP responses was signifi  cantly blunted 
(  Fig. 3, F and H  ). Similarly, when St-Ht31 and 59-74E 
  Figure 4.     GRKs mediate the sustained suppression of isoproterenol-induced cAMP signals. HEK-293 cells were exposed to 1   μ  M iso-
proterenol, followed by a 5-min washout, and a rechallenge with isoproterenol at the times indicated. Shown are representative traces 
of cells exposed to control intracellular solution (A) or cells exposed to intracellular solution containing PKI (B), 59-74E (C), or PKI + 
59-74E (D). (E) Ratio of the peak currents elicited by exposure to isoproterenol (second exposure/fi  rst exposure).         Xin et al.  357 
depicts simulations of the two pulse protocol.   Panels A, 
C, E, and G depict currents through CNG channels. 
Panels B, D, F, and H depict active receptor levels. 
In these simulations, active receptors are receptors in the 
surface membrane that have not been phosphorylated. 
While it is likely that the binding of arrestin, and not 
  To gain further insight into the molecular mecha-
nisms underlying the cAMP signals described above, 
we developed a mathematical model of the system. 
The model is summarized in the schematic depicted in 
  Fig. 5  .   Aspects of the model (e.g., PKA-mediated regula-
tion of PDE4 activity) have been published previously 
(Rich et al., 2007). According to this model,     2ARs cou-
ple to G  s   which in turn leads to activation of adenylyl 
cyclase (AC). Conversely, endogenous     2ARs do not 
couple to G  i   in HEK-293 cells, or, if they do, activation 
of G  i   has no signifi  cant effect on cAMP signals (  Fig. 3  ). 
Isoproterenol-induced increases in cAMP concentration 
subsequently lead to activation of PKA, which exerts its 
effects on cAMP signals through phosphorylation and 
stimulation of PDE4 activity. We have excluded other 
potential mechanisms of PKA-mediated feedback, such 
as phosphorylation of adenylyl cyclase or     2ARs, be-
cause we observed little or no PKA-mediated inhibition 
of forskolin-induced cAMP synthesis in HEK-293 cells 
(Rich et al., 2007). This indicates that PKA-dependent 
inhibition of adenylyl cyclase activity does not play a sig-
nifi  cant role in shutting down cAMP signals in HEK-293 
cells. In addition, we have assumed that at saturating 
isoproterenol concentrations there is little PKA-medi-
ated desensitization of     2AR because PKA inhibitors 
(10   μ  M H89) have no additional effects on isoproterenol-
induced cAMP accumulation in the presence of roli-
pram (  Fig. 2 B  ). This assumption is only valid at high 
agonist concentration where GRK-mediated desensiti-
zation of     2ARs is predominant (  Krasel et al., 2004, 
2005  ;   Tran et al., 2004  ;   Violin et al., 2006b  ). For a con-
sidered discussion of PKA-mediated desensitization 
of     2ARs, see   Whaley et al. (1994  ). The equations are 
detailed in the Materials and methods. 
  The model reproduces the experimental data pre-
sented (compare   Figs. 3 and 6  ).   In the presence of 
either PKI or 59-74E, the transient nature of the signal 
is maintained; however, in the presence of both PKI 
and 59-74E the decline in the signal is blunted.   Fig. 7   
  Figure 5.     Schematic presentation of the feedback mechanism 
primarily responsible for the regulation of       2   adrenergic signal-
ing in HEK-293 cells. Ligand binding to     2ARs leads to activation 
of adenylyl cyclase and cAMP production. cAMP activates PKA, 
which in turn phosphorylates and activates PDE4. GRK-mediated 
phosphorylation of the receptor, and subsequent arrestin bind-
ing, is also suffi  cient to trigger a decay in the near-membrane 
cAMP signal.     
  Figure 6.     Mathematical simulations of the system described by 
the schematic in   Fig. 5  . Panels on left depict the signal being 
measured, panels on right depict the underlying cAMP signals. 
(A and B) Simulations of normalized current through CNG chan-
nels (  I/I    max  ) due to isoproterenol-induced cAMP signals under 
control conditions. (C and D) Simulations of isoproterenol-
induced currents and cAMP signals in the presence of 20 nM PKI 
(included in the pipette solution). Including PKI in the pipette 
solution inhibits PKA-mediated stimulation of PDE activity, allow-
ing increased cAMP levels, but the signal is still transient due to 
basal PDE4 activity and GRK-mediated receptor desensitization. 
(E and F) Simulations describing the effect of GRK inhibition 
(3   μ  M 59-74E) on isoproterenol-induced signals. The signals are 
still transient due to PKA-mediated stimulation of PDE4 activity. 
(G and H) Simulations of currents and cAMP signals when both 
PKA and GRK activity are inhibited (with PKI and 59-74E). Inhib-
iting receptor desensitization and the stimulation of PDE4 activity 
prevents the decay of isoproterenol-induced signals.     358   Roles of GRK and PDE Activities in     2AR-mediated Signaling 
consistent with the possibility that we are not completely 
inhibiting GRK activity. Taken together, the data pre-
sented in   Figs. 1  –  4   and the simulations presented in 
  Figs. 6 and 7   strongly suggest that either GRK-mediated 
desensitization of     2ARs or PKA-mediated stimulation 
of PDE4 activity are suffi  cient to dampen cAMP signals 
during a sustained exposure to saturating concentrations 
of isoproterenol, and that GRK-mediated desensitiza-
tion is primarily responsible for the sustained suppression 
of     2AR-mediated signals. 
  We next used this model to examine the effects of in-
creasing basal adenylyl cyclase activity on the respon-
siveness of the system (  Fig. 8  ).   We let the system reach 
equilibrium at each level of basal adenylyl cyclase activ-
ity (in the absence of receptor activation) to determine 
the initial conditions (e.g., initial cAMP levels, PKA and 
PDE activities, etc.). Interestingly, in the presence of 
small (twofold) increases in basal adenylyl cyclase activ-
ity, receptor-mediated cAMP signals were markedly 
slower with smaller amplitudes. These effects were due 
to the increased basal cAMP levels activating PKA, and, 
  receptor phosphorylation, is responsible for desensitiz-
ing the receptor (by blocking receptor  –  G protein inter-
actions), the binding of arrestin to phosphorylated 
receptors is fast compared with the rate of GRK-medi-
ated phosphorylation (  Krasel et al., 2004, 2005  ), and 
therefore is not considered in the model. 
  Simulations describing the system under control con-
ditions or in the presence of 20 nM PKI show small re-
sponses to the second pulse of isoproterenol, consistent 
with the experimental observations (  Fig. 7, A and B  ). 
Under these conditions, active receptor levels are still 
low at the end of the wash period (  Fig. 7, B and D  ), thus 
there are few receptors (    16%) available to respond to 
a second pulse of isoproterenol. However, simulations 
describing the system in the presence of 59-74E show a 
marked increase in the number of receptors present 
(  Fig. 7 F  ), and a substantial response to the second pulse 
of isoproterenol (  Fig. 7 E  ). Interestingly, simulations de-
picting both PKI and 59-74E in the patch pipette (  Fig. 7, 
G and H  ) show a slightly higher second response than ex-
perimental observations (compare   Fig. 6 D   with Fig. 7 G), 
  Figure 7.     Simulations of the recovery of isoprote-
renol-induced signals following a 5-min stimulation 
and a 5-min washout (the two-pulse protocol). The 
simulations depict the response of the system to an 
initial 5-min exposure to 1   μ  M isoproterenol, fol-
lowed by a 5-min wash, and then a second exposure 
to 1   μ  M isoproterenol. Under control conditions 
(A), and in the presence of 20 nM PKI (C), only 
small currents are induced by a second exposure 
to isoproterenol. (B and D) This was primarily due 
to a reduction in the number of active receptors. 
(E and F) Inhibition of GRK activity with 3   μ  M 59-
74E allows a second isoproterenol response that is 
substantially larger (    50% of the peak response to 
the initial pulse) due to an increased number of re-
ceptors at the start of the second pulse. (G and H) 
In the presence of both PKI and 59-74E, the cAMP 
response was further increased, due to the increased 
number of receptors at the start of the second pulse, 
and the loss of PKA-mediated regulation of PDE ac-
tivity. These simulations are consistent with the data 
presented in   Fig. 4  .         Xin et al.  359 
idly reached concentrations higher than the   K    m   of the 
PDE (    1   μ  M)). At low receptor levels, basal PDE activ-
ity caused a further reduction in effi  cacy (  Fig. 9, com-
pare B and D  ). 
  In the simulations depicted in   Fig. 9 (E and F)  , PKA-
mediated stimulation of PDE4 activity was left intact. 
This allowed us to examine the effects of PKA-mediated 
stimulation of PDE activity in conjunction with receptor 
desensitization. The simulations demonstrate that when 
receptor levels were high, stimulation of PDE activity 
caused an additional loss of sensitivity (an additional 
right shift in the dose  –  response curve,   Fig. 9 E  ). When 
the receptor levels were low, PDE activity further blunted 
cAMP accumulation during the second isoproterenol 
pulse (  Fig. 9 F  ). These simulations reveal the extent to 
which receptor desensitization as well as basal and stim-
ulated PDE activities suppress cAMP signals. 
  DISCUSSION  
  Early studies quantitatively examined the complex inter-
play between receptor desensitization and PDE activity 
in controlling cAMP signals (  Barber et al., 1984, 1992  ; 
  Barber, 1986  ). Since that time, a wide range of work has 
identifi  ed the molecular components of     2AR desensi-
tization and the regulation of PDE activity (for reviews 
see   Houslay et al., 1998  ;   Clark et al., 1999  ;   Gainetdinov 
et al., 2004  ;   Wang et al., 2006  ;   Conti and Beavo, 2007  ; 
  DeWire et al., 2007  ). However, relatively few studies 
have further examined the interplay between desensitiz-
ation and PDE activity in regulating cAMP levels, and a 
majority of these studies have relied on either the over-
expression or knockdown of     2ARs. In the present work 
we have taken a slightly different approach. We investi-
gated an endogenous signaling system by monitoring 
isoproterenol-induced cAMP signals in HEK-293 cells 
using CNG channels as real-time cAMP sensors. We ob-
served that activation of endogenous     2ARs with iso-
proterenol (1   μ  M) triggers transient cAMP signals. The 
time course of the decline of these signals is similar to 
the time course of PDE4 activation (  Fig. 2  ), as well as 
GRK-mediated     2AR phosphorylation and subsequent 
receptor desensitization (  Seibold et al., 2000  ;   Krasel et al., 
2004, 2005  ;   Tran et al., 2004  ). Interestingly, inhibition 
in turn, PKA stimulating PDE4 activity. In essence, 
  increased basal adenylyl cyclase activity primed PDE-
mediated feedback on subsequent cAMP signals. 10-fold 
increases in basal adenylyl cyclase activity triggered even 
further reductions in the peak cAMP levels. The higher 
basal adenylyl cyclase activity also largely eliminated the 
transient nature of the response, again due to increased 
PKA and PDE activity. 
  Lastly, we used this model to investigate the inter-
actions between receptor levels, GRK-mediated recep-
tor desensitization, and PKA-mediated stimulation of 
PDE4 activity in regulating isoproterenol-induced cAMP 
signals by comparing peak cAMP levels elicited during 
the fi  rst and second stimulation of the two pulse proto-
col (  Fig. 9  ).   The black circles depict peak cAMP levels 
in response to different isoproterenol concentrations 
measured during the fi  rst isoproterenol pulse. The 
open circles depict the cAMP levels in response to dif-
ferent isoproterenol concentrations measured at the 
end of the second isoproterenol pulse (following a 
5-min pulse to 1   μ  M isoproterenol and 5-min wash). 
It should be noted that, as stated above, the effects 
of PKA-mediated desensitization of     2ARs were not 
modeled; thus, cAMP levels may be overestimated at 
low ligand concentrations. 
  Simulations were used to investigate the effects of 
receptor levels and PDE activity on cAMP signals. In the 
simulations depicted in   Fig. 9 (A and B)  , PDE activity 
was inhibited with 10   μ  M rolipram. When receptor levels 
were high, receptor desensitization primarily caused 
a loss of sensitivity (    threefold right shift in the dose  –
  response curve,   Fig. 9 A  ); whereas, when receptor levels 
were low, receptor desensitization caused a loss of effi  -
cacy (    50% reduction in cAMP levels,   Fig. 9 B  ). 
  In the simulations depicted in   Fig. 9 (C and D)  , PKA-
mediated stimulation of PDE4 activity was inhibited 
with 20 nM PKI. This allowed us to determine the ef-
fects of basal PDE activity and receptor desensitization 
on the responsiveness of the system. At high receptor 
levels, receptor desensitization caused a similar right 
shift in the isoproterenol dose  –  response (  Fig. 9, com-
pare A and C  ), as well as a reduction in the effi  cacy. The 
reduction in effi  cacy was more pronounced at higher 
agonist concentrations (at which cAMP levels more rap-
  Figure 8.     Simulated effects of increased basal 
AC activity on     2AR-mediated cAMP signaling. 
(A and B)Increasing basal adenylyl cyclase 
activity from control levels of 0.005   μ  M/s to 
0.05   μ  M/s increased both the basal PKA and PDE 
activities, in essence priming the negative feed-
back loop. The effects of this priming phenom-
ena were (B) smaller cAMP signals leading to (A) 
de  creased peak currents through CNG channels. 
In addition, the overall kinetics of the signal 
were slowed with increased basal AC activity, and, 
at the highest basal AC activity shown, were no 
longer transient.     360   Roles of GRK and PDE Activities in     2AR-mediated Signaling 
PKA inhibitors during a second pulse of isoproterenol, 
we observed that GRK-mediated desensitization is pri-
marily responsible for a more sustained suppression 
of     2AR-mediated signaling. In addition, the high reso-
lution cAMP measurements presented here have al-
lowed us to develop a kinetic model of this system 
(discussed below). 
  Local PDE4 Activity Is Sufﬁ  cient to Ensure Transient 
cAMP Signals 
  Several recent studies have identifi   ed other mecha-
nisms that may contribute to the regulation of cAMP 
signals in HEK-293 cells. For example, it has been pro-
posed that PDE4 binds to arrestin and is subsequently 
recruited to the receptor (  Perry et al., 2002  ;   Houslay and 
Baillie, 2005  ). This process would allow PDE4 to regu-
late PKA-mediated phosphorylation of     2ARs (  Houslay 
and Baillie, 2005  ). In addition, it has been suggested 
that PKA-mediated phosphorylation triggers a switch in 
the coupling of     2ARs from G  s   to G  i   (  Daaka et al., 1997  ; 
  Houslay and Baillie, 2005  ;   Lynch et al., 2005  ); however, 
the existence of this switch remains controversial and 
may be cell type specifi  c (  Friedman et al., 2002  ;   Schmitt 
and Stork, 2002  ). Although we did not directly test 
for arrestin recruitment of PDE4, previous work (  Rich 
et al., 2001a, 2007  ;   Willoughby et al., 2006  ) and the re-
sults presented here suggest that PKA-mediated stimu-
lation of resident PDE4 activity is suffi  cient to dampen 
cAMP signals, even in the presence of sustained ad-
enylyl cyclase activity. In addition, the data presented 
here demonstrate that treatment with PTX alone, or in 
conjunction with the GRK inhibitor 59-74E, does not 
signifi  cantly alter isoproterenol-induced cAMP signals 
mediated by endogenous     2ARs. As such, it is improb-
able that in this system PKA-mediated phosphorylation 
switches the coupling of an appreciable fraction of     2ARs 
from G  s   to G  i  . Recently, two other groups have come 
to similar conclusions regarding the coupling of endog-
enous     2ARs to G  i   in HEK-293 cells (  Willoughby et al., 
2007  ;   Violin et al., 2008  ). 
  One likely explanation for the differences in the re-
sults of these studies is that much of the work investigat-
ing molecular mechanisms of       2   adrenergic signaling 
has relied on overexpression systems. HEK-293 cells are 
often used in these studies because they express low lev-
els of endogenous     2ARs. High levels of overexpressed 
receptors are likely to facilitate low occurrence molecu-
lar interactions, such as     2AR coupling to G  i  . In addi-
tion, we have found that stable overexpression of     2ARs 
triggers a substantial up-regulation of PDE types 1, 3, 
and 4 (unpublished data). Expression levels of other 
relevant proteins, such as GRKs and arrestins, also may 
be affected. As such, molecular interactions identifi  ed 
in studies using overexpressed     2ARs may be more con-
sistent with cell types expressing high local receptor 
levels, such as cardiac myocytes. 
of either GRK or PKA activity does not signifi  cantly alter 
the time course of the response; whereas inhibition of 
both GRK and PKA activities signifi  cantly reduces the 
decline in the signal. These data strongly support the 
hypothesis that both receptor desensitization and PKA-
mediated stimulation of PDE4 activity are individually 
capable of generating a decline in the transient re-
sponse, and that both processes occur over a similar 
time frame. When we examined the effects of GRK and 
  Figure 9.     Simulations demonstrate the effects of receptor levels 
on [cAMP] in the absence and presence of PDE4 activity. Solid 
circles represent normalized peak cAMP levels (from model sim-
ulations) in response to a 5-min stimulation with isoproterenol. 
Open circles represent cAMP levels measured at the end of the 
second stimulation with isoproterenol (following a 5-min stimula-
tion with 1   μ  M isoproterenol followed by a 5-min wash). (A  –  F) 
The effects of receptor desensitization in the following scenarios: 
(A) high receptor levels (100   μ  M) and PDE4 activity inhibited 
(10   μ  M rolipram); (B) low receptor levels (1   μ  M) and PDE ac-
tivity inhibited; (C) high receptor levels with basal PDE activity 
(20 nM PKI to inhibit PKA activity); (D) low receptor levels with 
basal PDE activity; (E) high receptor levels and PKA-mediated 
regulation of PDE activity intact; (F) low receptor levels and PKA-
mediated regulation of PDE activity intact.         Xin et al.  361 
clearly demonstrate that both GRK-mediated desensitiza-
tion of     2ARs and PKA-mediated stimulation of resident 
PDE4 activity can generate declines in agonist-induced 
cAMP signals, consistent with our interpretation of the 
data presented here. The simulations also demonstrate 
the critical importance of basal adenylyl cyclase activity. 
Small increases in adenylyl cyclase activity trigger modest 
increases in PKA activity, which, in turn, stimulate basal 
PDE activity. The increased basal PDE activity dramati-
cally affects the kinetics of subsequent, agonist-induced 
cAMP signals, slowing the kinetics of the signals and 
reducing peak cAMP levels. Our model predicts that 
at higher basal adenylyl cyclase activities, cAMP signals 
would no longer be transient. These results are consis-
tent with previous studies of photoreceptors in which ba-
sal PDE activity had profound effects on the kinetics of 
the light response (  Nikonov et al., 1998  ;   Nikonov et al., 
2000  ). Both the results of Nikonov et al. and those presen -
ted here demonstrate that slight increases in cyclase or 
PDE activity may have dramatic effects on the amplitude 
and kinetics of agonist-induced responses. 
  The simulations also reveal that in the absence of 
PDE activity, receptor desensitization caused a loss of 
sensitivity in cells with high receptor levels and a loss of 
effi  cacy in cells with low receptor levels (  Fig. 9  ). Thus, 
these simulations are consistent with earlier studies that 
quantitatively examined     2AR desensitization (  Barber 
et al., 1984  ;   Barber, 1986  ;   Whaley et al., 1994  ;   Clark 
et al., 1999  ). The models presented here allowed us to 
examine the effects of receptor desensitization in the 
presence of PDE activity. In this case, simulations re-
vealed that, together, these processes were responsible 
for reductions in the sensitivity and effi  cacy of the sys-
tem. We believe this overall approach is critical for un-
derstanding the potential roles of a variety of feedback 
mechanisms in regulating second messenger systems. 
  Our experimental data and mathematical simulations 
dem  onstrate important differences between isoprote-
renol- and PGE  1  -induced cAMP signals. Both GPCR 
agonists trigger transient cAMP responses, yet the mech-
anisms underlying these responses are different. As 
de      s        cribed here, both GRK-mediated receptor desensi-
tization and PKA-mediated stimulation of PDE4 activity 
contribute to the decay in isoproterenol-induced cAMP 
signals; whereas, PKA-mediated stimulation of PDE4 
activity is primarily responsible for the decay in PGE  1  -
induced signals. This important difference is critical to 
how each system responds to subsequent regulation. For 
example, our data and simulations clearly demonstrate 
that prolonged exposure to isoproterenol dramatically 
reduces the rate of cAMP synthesis. Thus, a subsequent 
reduction in PDE activity (e.g., by ERK-mediated phos-
phorylation of PDE4) or an increase in adenylyl cyclase 
activity (e.g., by Ca 
2+  -calmodulin  –  mediated stimulation 
of adenylyl cyclase type 8) would lead to attenuated 
changes in cAMP levels. Conversely, following prolonged 
  More recently, siRNA techniques were used to identify 
specifi  c proteins that regulate cAMP signals in HEK-293 
cells. Willoughby et al. (2007) presented data indicating 
that     -arrestin 2 and specifi  c PDE4D subtypes regulate 
cAMP signals near the plasma membrane of these cells. 
They did not examine the effects of siRNA-mediated 
knockdown of these proteins on other components of 
the cAMP signaling pathway, such as receptor levels, ad-
enylyl cyclase activity, or basal cAMP levels. The results 
presented here demonstrate that small changes in basal 
cAMP levels have dramatic effects on agonist-induced 
signals. Hence, great care must be taken in interpreting 
the effects of siRNA-mediated knockdown of proteins 
on agonist-induced cAMP signals. Regardless, the data 
presented by these authors clearly implicate the involve-
ment of     -arrestin 2, PDE4D3, and PDE4D5 in the regu-
lation of cAMP signals in HEK-293 cells. 
  The roles of specifi  c GRKs are less well established. 
Early studies suggested that GRK2 was primarily re-
sponsible for GRK-mediated phosphorylation of     2ARs 
(  Krupnick and Benovic, 1998  ). More recently, two groups 
presented data indicating that GRK5 and GRK6 may play 
important roles in the phosphorylation of     2ARs (  Tran 
et al., 2007b  ;   Violin et al., 2008  ). Clearly, further research 
using a variety of techniques will be required to clarify 
the potential roles of different GRK subtypes in the 
regulation of     2AR signaling. 
  Mathematical Modeling of Second Messenger Systems 
  Recently investigators have begun to use a variety of 
mathematical modeling techniques to describe signal-
ing systems (  Bhalla and Iyengar, 1999  ;   Rich et al., 2000  ; 
  Saucerman et al., 2003, 2006  ;   Suh et al., 2004  ;   Iancu et al., 
2007  ). These approaches, when used in conjunction 
with carefully controlled experimental data, have given 
insight into both the possible and actual signaling para-
digms. For example, early experimental work provided 
strong experimental evidence for the subcellular com-
partmentalization of cAMP signals (  Manganiello and 
Vaughan, 1973  ;   Corbin and Keely, 1977  ;   Brunton et al., 
1981  ;   Jurevicius and Fischmeister, 1996  ). Further evi-
dence was provided by the discovery of the ubiquitous 
scaffolding proteins, AKAPs (  Sarkar et al., 1984  ;   Bregman 
et al., 1989  ;   Wong and Scott, 2004  ). More recently, a 
series of quantitative studies used modeling in conjunc-
tion with experimental approaches to estimate the ef-
fective diffusion coeffi  cient for cAMP ( Rich et al., 2000 ), 
predict effects of cAMP and cGMP compartmentalization 
(  Rich et al., 2001a  ;   Piggott et al., 2006  ), and examine 
signals triggered by different GPCR agonists as well as 
subcellular gradients of cAMP (  Saucerman et al., 2006  ; 
  Iancu et al., 2007  ;   Warrier et al., 2007  ). 
  Here we used mathematical models to unravel the com-
plex interactions between receptor levels, receptor desen-
sitization, and regulation of PDE activity in controlling 
the sensitivity and effi  cacy of this system. The simulations 362   Roles of GRK and PDE Activities in     2AR-mediated Signaling 
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exposure to PGE  1  , adenylyl cyclase activity is still high, 
as is PDE4 activity (  Rich et al., 2001a  , 2007). Subsequent 
inhibition of PDE activity or stimulation of adenylyl 
cyclase activity will lead to rapid increases in cAMP levels. 
Thus, the two GPCR systems are inherently different. 
In other words, GRK-mediated desensitization not only 
desensitizes initial GPCR signals, it also, in effect, lim-
its subsequent cAMP production. In systems in which 
GRK-mediated desensitization occurs more slowly (or 
in cellular systems with spare receptors stimulated by 
high concentrations of agonist), sustained receptor ac-
tivation leads to increased rates of cAMP production 
and hydrolysis; therefore small changes in PDE or AC 
activity lead to rapid changes in cAMP levels. 
  In conclusion, we have resolved the kinetics of     2AR-
triggered cAMP signals in HEK-293 cells. In addition, 
we have used experimental and mathematical modeling 
approaches to estimate the relative contributions of GRK-
mediated desensitization of     2ARs and PKA-mediated 
stimulation of PDE4 activity in suppressing cAMP signals. 
The use of mathematical modeling has also allowed us 
to probe the effects of receptor levels on this signaling 
system, making it possible to extrapolate from the re-
sults presented here to other cellular environments. 
As such, this work represents an initial step toward the 
quantitative understanding of cAMP signaling systems. 
What remains to be determined are the local concen-
trations of relevant enzymes, including receptors, 
G proteins, adenylyl cyclase, and phosphodiesterase. 
Revealing the subcellular concentrations and kinetics 
of these key signaling enzymes in different cellular 
settings is the next critical step in understanding how 
signaling specifi  city is achieved. 
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